Since the nineties, the incidence of sporadic early-onset (EO) cancers has been rising worldwide. The underlying reasons are still unknown. However, identifying them is vital for advancing both prevention and intervention. Here, we exploit available knowledge derived from clinical observations to formulate testable hypotheses aimed at defining the causal factors of this epidemic and discuss how to experimentally test them. We explore the potential impact of exposome changes from the millennials to contemporary young generations, considering both environmental exposures and enhanced susceptibilities to EO-cancer development. We emphasize how establishing the time required for an EO cancer to develop is relevant to defining future screening strategies. Finally, we discuss the importance of integrating multi-dimensional data from international collaborations to generate comprehensive knowledge and translate these findings back into clinical practice.

Early-onset cancers: Biological bases and clinical implications / G. Mauri, G. Patelli, A. Sartore-Bianchi, S. Abrignani, B. Bodega, S. Marsoni, V. Costanzo, A. Bachi, S. Siena, A. Bardelli. - In: CELL REPORTS MEDICINE. - ISSN 2666-3791. - 5:9(2024 Sep 17), pp. 101737.1-101737.14. [10.1016/j.xcrm.2024.101737]

Early-onset cancers: Biological bases and clinical implications

G. Mauri
Co-primo
;
G. Patelli
Co-primo
;
A. Sartore-Bianchi;S. Abrignani;B. Bodega;V. Costanzo;S. Siena
Penultimo
;
2024

Abstract

Since the nineties, the incidence of sporadic early-onset (EO) cancers has been rising worldwide. The underlying reasons are still unknown. However, identifying them is vital for advancing both prevention and intervention. Here, we exploit available knowledge derived from clinical observations to formulate testable hypotheses aimed at defining the causal factors of this epidemic and discuss how to experimentally test them. We explore the potential impact of exposome changes from the millennials to contemporary young generations, considering both environmental exposures and enhanced susceptibilities to EO-cancer development. We emphasize how establishing the time required for an EO cancer to develop is relevant to defining future screening strategies. Finally, we discuss the importance of integrating multi-dimensional data from international collaborations to generate comprehensive knowledge and translate these findings back into clinical practice.
Settore MEDS-02/A - Patologia generale
Settore BIOS-08/A - Biologia molecolare
   Building a reproducible single-cell experimental workflow to capture tumour cell persistence
   PERSIST-SEQ
   European Commission
   Horizon 2020 Framework Programme
   101007937

   Una rete oncologica regionale che affronta il problema emergente del cancro del colonretto giovanile utilizzando l’integrazione di approcci amici per decifrare meccanismi di immunoediting del cancro come potenziali bersagli di nuove terapie (IANG-CRC)
   IANG-CRC
   FONDAZIONE REGIONALE PER LA RICERCA BIOMEDICA
   CP2_12/2018

   Targeting DNA repair pathways, sparking anti cancer immunity
   TARGET
   European Commission
   Horizon 2020 Framework Programme
   101020342
17-set-2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S2666379124004671-main.pdf

accesso aperto

Descrizione: article
Tipologia: Publisher's version/PDF
Dimensione 2.91 MB
Formato Adobe PDF
2.91 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1116083
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 0
social impact